Pro-Dex Q4 revenue falls 15% YoY; full-year sales up 9%

PRO DEX INC

2021-FY EPS reported $1.13 revenue$38,029,000

Q4 net sales $9.4M (-15% YoY); net income $0.9M ($0.22 diluted EPS) vs $2.5M ($0.64) prior year.
FY2021 net sales $38.0M (+9% YoY); net income $4.5M ($1.13 EPS) down from $6.1M ($1.50).
Operating expenses up 49% to $9.1M, driven by increased R&D ($2.1M) and stock compensation ($615K).
R&D pipeline: ENT Shaver launches Q4 2021 (est. $1M annual rev); Vital Ventilator targets Q1 2022 ($1.5M est.).
COVID-19 caused under-absorbed manufacturing costs; supply chain delays ongoing.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.